The pharmaceutical industry is one of the few sectors that has not experienced economic losses despite the pandemic. In fact, since that period, it has been an even more key sector, not only for maintaining its production, guaranteeing the continuity of treatments, but also for seeking an effective vaccine against covid-19.
Although the situation faced by the pharmaceutical sector during COVID-19, according to data from Pharmaceutical Technology, meant a five-year acceleration in the digital transformation processes, there are still companies in the sector that have very specific work methodologies. traditional. Many of them have a correct digitization of the business layer (ERP) and the control layer (SCADA). However, most still have a great challenge ahead with the digitization of the operational layer with MES-type software, since many factory operations are managed with paper or tools that are not designed for it, such as Office.
For this reason, the pharmaceutical sector still has to continue advancing in its digital transformation. Being a vital sector, it is very important that it can supply the existing demand, despite possible fluctuations in the market or drastic changes such as the pandemic. Having efficient technological solutions not only allows them to increase their production and reduce costs, but also helps them adapt to the demanding quality requirements and guarantee the end-to-end traceability of their product.
From Geprom | Part of Telefonica Tech, we want to help the pharmaceutical sector address the challenges it faces in its digital transformation.
In this article, we will focus on how a MES System in the pharmaceutical sector helps you to:
- Increase production
- Reduce costs
- Integrate systems and data
- Maintain traceability throughout the production chain
- Record deviations and nonconformities
- Monitor the performance of production lines